Krishgen offers its KRIBIOLISA™ biomonitoring assays for vaccines. These assays are well validated as per ICH/WHO guidelines and enable researchers and clinicians to monitor the vaccines
They provide vaccine companies, research labs, and other scientists with critical diagnostic tests based on sensitive test format to help ensure the accurate and timely diagnosis, enhancing the productivity and quality of the research.
The titer of antibodies produced by vaccination can be used to confirm whether the vaccination has been successful.
Our ELISA kits have been validated and have the following key features -
easy to use (both for manual and automation)
available with positive and negative controls
pack of 96 wells with well characterized antibodies
Dr Jayaraman D. Lead Scientist, leading CRO company
I have been working with a team from KRISHGEN on an assay development and customization before giving us. The project was complicated and needed technical expertise in immunology. I was very pleased with their technical competence and also mastering immunology and delivering a tough project to us on time. Their rigor, punctuality and expertise have been a recipe for the high standards, I would expect for such project from them. Kudos, Krishgen Team!!!
Mr Ramesh Sravanan, VP-Supply Chain
The expertise and command on the logistics chain including the regulatory
guidelines from Krishgen is something we admire. As they often indicate, let us
do the supplies, and let your team focus on science … is really something the
company works on. Delivering consistently, with less than 1% error or delay
consistently is the key to their success.
Dr Keith Stevens, visiting Scientist, Norfolk University, UK
To have a company understand science and work with them, is a pleasure. Krishgen
not only sells but understands what it sells in terms of the complex cutting
Mellisa Karlowski, Lead Researcher, east coast US CRO
The company is good on understanding its customers, is transparent and
speaks science. This makes it easier for us to work with them.